Repurposing chlorpromazine to treat COVID-19: The reCoVery study

AC Petit - L'encephale, 2020 - Elsevier
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …

Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

M Plaze, D Attali, AC Petit, M Blatzer, E Simon-Loriere… - L'encephale, 2020 - europepmc.org
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …

Repurposing chlorpromazine to treat COVID-19: The reCoVery study

M Plaze, D Attali, AC Petit, M Blatzer… - L' …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …

[HTML][HTML] Repurposing chlorpromazine to treat COVID-19: The reCoVery study

M Plaze, D Attali, AC Petit, M Blatzer… - L'Encephale, 2020 - ncbi.nlm.nih.gov
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …

Repurposing chlorpromazine to treat COVID-19: The reCoVery study

M Plaze, D Attali, AC Petit, M Blatzer, E Simon-Loriere… - L'Encéphale, 2020 - hal.science
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …

Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

M Plaze, D Attali, AC Petit, M Blatzer, E Simon-Loriere… - L'encephale, 2020 - europepmc.org
Objectives The ongoing COVID-19 pandemic has caused approximately 2,350,000
infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital …